Expert: Sinopharm’s COVID-19 vaccine can make a great contribution to the global vaccine rollout

CGTN published this video item, entitled “Expert: Sinopharm’s COVID-19 vaccine can make a great contribution to the global vaccine rollout” – below is their description.

For more:

https://www.cgtn.com/video

Dr. Jerome H. Kim, director-general of the International Vaccine Institute, said the COVID-19 Vaccine Global Access (COVAX) expects to deliver at least 2 billion doses of vaccine by the end of this year, which is unprecedented in history. He hoped that after Sinopharm’s COVID-19 vaccine is approved by the World Health Organization, it can make a great contribution to the global vaccine rollout by taking advantage of its production capacity. He said COVAX understands the efficacy and safety of the Sinopharm vaccine.

CGTN YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • China declares Shenzhou-12 mission a complete success
  • Live: Chinese astronauts to return home after 3-month space mission
  • Shenzhou-12 spaceship successfully lands in north China
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Tracking Australia’s COVID-19 vaccine rollout: September 17 | ABC News
  • ‘No decisions taken yet on travel rules’ says Environment Secretary
  • WHO’s Science in 5 on COVID-19: Mixed and fractional vaccine doses
  • Covid-19: Overhaul of international travel rules expected @BBC News live 🔴 BBC
  • Victoria’s COVID cases and hospitalisation increasing, rising deaths in NSW | ABC News
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • China’s Sinopharm debuts new vaccines targeting COVID-19 variants
  • China donates medical supplies to Myanmar
  • In This Story: World Health Organization

    The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency’s governing structure and principles, states its main objective as “the attainment by all peoples of the highest possible level of health.”

    3 Recent Items: World Health Organization

  • WHO’s Science in 5 on COVID-19: Mixed and fractional vaccine doses
  • De Blasio Says Covid Vaccinations Required at UN General Assembly
  • 2021年世界患者安全日
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.